These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glucocorticoids, feto-placental 11 beta-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Seckl JR Steroids; 1997 Jan; 62(1):89-94. PubMed ID: 9029721 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms. Seckl JR Mol Cell Endocrinol; 2001 Dec; 185(1-2):61-71. PubMed ID: 11738795 [TBL] [Abstract][Full Text] [Related]
5. Physiologic programming of the fetus. Seckl JR Clin Perinatol; 1998 Dec; 25(4):939-62, vii. PubMed ID: 9891623 [TBL] [Abstract][Full Text] [Related]
6. Tissue-specific messenger ribonucleic acid expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 and the glucocorticoid receptor within rat placenta suggests exquisite local control of glucocorticoid action. Waddell BJ; Benediktsson R; Brown RW; Seckl JR Endocrinology; 1998 Apr; 139(4):1517-23. PubMed ID: 9528929 [TBL] [Abstract][Full Text] [Related]
7. Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. McTernan CL; Draper N; Nicholson H; Chalder SM; Driver P; Hewison M; Kilby MD; Stewart PM J Clin Endocrinol Metab; 2001 Oct; 86(10):4979-83. PubMed ID: 11600574 [TBL] [Abstract][Full Text] [Related]
8. Dual function of 11beta-hydroxysteroid dehydrogenase in placenta: modulating placental glucocorticoid passage and local steroid action. Burton PJ; Waddell BJ Biol Reprod; 1999 Feb; 60(2):234-40. PubMed ID: 9915986 [TBL] [Abstract][Full Text] [Related]
9. The ontogeny of 11 beta-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Brown RW; Diaz R; Robson AC; Kotelevtsev YV; Mullins JJ; Kaufman MH; Seckl JR Endocrinology; 1996 Feb; 137(2):794-7. PubMed ID: 8593833 [TBL] [Abstract][Full Text] [Related]
10. The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero. Bertram C; Trowern AR; Copin N; Jackson AA; Whorwood CB Endocrinology; 2001 Jul; 142(7):2841-53. PubMed ID: 11416003 [TBL] [Abstract][Full Text] [Related]
11. Placental insufficiency and its effect on the fetus and adult disease. Merlet-Benichou C; Leroy B; Gilbert T; Lelievre-Pegorier M Lancet; 1993 Mar; 341(8848):827-8. PubMed ID: 8096026 [No Abstract] [Full Text] [Related]
12. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Murphy VE; Smith R; Giles WB; Clifton VL Endocr Rev; 2006 Apr; 27(2):141-69. PubMed ID: 16434511 [TBL] [Abstract][Full Text] [Related]
13. [The actions of glucocorticoid receptor and 11 beta-hydroxysteroid dehydrogenases in the brain]. Wan SL; Xu JJ; Sun G Sheng Li Ke Xue Jin Zhan; 2001 Apr; 32(2):171-3. PubMed ID: 12545895 [No Abstract] [Full Text] [Related]
14. Variations in human placental 11 beta-dehydrogenase and 11-oxoreductase activities of 11 beta-hydroxysteroid dehydrogenase enzyme during pregnancy. Muneyyirci-Delale O; Lakshmi V; McCalla CO; Karacan M; Neil G; Camilien L Early Pregnancy; 1996 Sep; 2(3):201-6. PubMed ID: 9363218 [TBL] [Abstract][Full Text] [Related]
15. 11-beta-hydroxysteroid dehydrogenase: on several roads to hypertension. Seckl JR; Brown RW J Hypertens; 1994 Feb; 12(2):105-12. PubMed ID: 8021460 [No Abstract] [Full Text] [Related]
16. Medical and physiological aspects of the 11beta-hydroxysteroid dehydrogenase system. Seckl JR; Chapman KE Eur J Biochem; 1997 Oct; 249(2):361-4. PubMed ID: 9370341 [TBL] [Abstract][Full Text] [Related]
17. Low-birthweight hypertension via enzyme and receptor imprintings of glucocorticoid. Oka K; Hirano T; Homma M Lancet; 1993 Jul; 342(8866):303-4. PubMed ID: 8101326 [No Abstract] [Full Text] [Related]
18. Impact of restriction of placental and fetal growth on expression of 11beta-hydroxysteroid dehydrogenase type 1 and type 2 messenger ribonucleic acid in the liver, kidney, and adrenal of the sheep fetus. McMillen IC; Warnes KE; Adams MB; Robinson JS; Owens JA; Coulter CL Endocrinology; 2000 Feb; 141(2):539-43. PubMed ID: 10650933 [TBL] [Abstract][Full Text] [Related]
19. Genetic approaches to determine the role of glucocorticoid signaling in osteoblasts. Harrison JR; Woitge HW; Kream BE Endocrine; 2002 Feb; 17(1):37-42. PubMed ID: 12014702 [TBL] [Abstract][Full Text] [Related]